Xytis
closedBiopharmaceutical company focusing on the discovery and development of innovative central nervous system drug candidates.
Launch date
Employees
Market cap
-
Enterprise valuation
€89—134m (Dealroom.co estimates Jan 2006.)
Company register number 05116784
Irvine California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$24.5m | Series B | ||
Total Funding | €22.3m |
Recent News about Xytis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.